A New Omicron Subvariant, Dubbed ‘Eris,’ Heralds Covid-19’s Resurgence
[ad_1] What to Read Next [ad_2] Source link
outbreaks
Read More
U.S. and China Poised to Drift Further Apart After Investment Ban
[ad_1] What to Read Next [ad_2] Source link
Why Trucking Giant Yellow’s Shutdown Could Cost Taxpayers Money
[ad_1] Whether the federal government recovers the money it lent Yellow at the height of the pandemic would likely depend…
WSJ News Exclusive | Facebook Bowed to White House Pressure, Removed Covid Posts
[ad_1] Facebook removed content related to Covid-19 in response to pressure from the Biden administration, including posts claiming the virus…
As China Reopens Borders, Trafficking of Women and Girls Resumes
[ad_1] June 29, 2023 11:00 pm ET Listen to article (2 minutes) Covid-19 and a daunting wall China erected along…
Opinion | New York vs. Florida on Covid, by the Numbers
[ad_1] Even using Trump’s dubious standard, DeSantis’s state outperformed Cuomo’s. [ad_2] Source link
Pro Take: Are There More Workers to Pull Into the U.S. Economy?
[ad_1] Friday’s employment report blew away projections: 339,000 new jobs. Federal Reserve officials believed labor-market tightness was easing, but the…
Essay | The New Everyday Reality of Service Robots
[ad_1] The pandemic may be over, but the demand for nonhuman workers in health care, food service and other fields…
Global Trade Jumped in March, According to WSJ Indicator
[ad_1] Global trade flows jumped in March, led by a surge in Chinese exports following the removal of Covid-19 restrictions…
Pfizer’s Earnings Fall With Cooling Demand for Covid Products
[ad_1] Excluding revenue from Comirnaty and Pfizer’s Covid-19 pill Paxlovid, the company’s top line increased 5%. [ad_2] Source link